Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)

Market Cap	3.83B +163.6%
Revenue (ttm)	2.31B +59.6%
Net Income	513.05M +96.4%
EPS	34.35 +96.1%
Shares Out	14.93M
PE Ratio	7.46
Forward PE	n/a
Dividend	16.74 (6.61%)
Ex-Dividend Date	Nov 12, 2025

Volume	3,680
Average Volume	8,512
Open	253.29
Previous Close	253.29
Day's Range	253.64 - 263.00
52-Week Range	97.03 - 315.00
Beta	0.11
RSI	32.88
Earnings Date	Feb 12, 2026

About EGX:CPCI

Kahira Pharmaceuticals & Chemical Industries Company manufactures, packages, distributes, and trades in pharmaceutical products in Egypt and internationally. It offers various pharmaceutical dosage forms, medical preparations, cosmetics, chemicals, extracts, veterinary medicines, and pesticides. The company is also involved in support services, including combination formulations. It exports its products to Sudan, Jordan, Yemen, Iraq, Djibouti, Somalia, South Sudan, Mali, Niger, Senegal, and Libya. The company was founded in 1962 and is headquar...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 1,735
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: CPCI

Financial Performance

In fiscal year 2025, EGX:CPCI's revenue was 2.08 billion, an increase of 52.80% compared to the previous year's 1.36 billion. Earnings were 443.72 million, an increase of 80.29%.